Finasteride Dosage: 1mg vs 5mg, Microdosing, and What Actually Matters

Finasteride dosing is one of those topics where the marketing muddies the science. There are two FDA-approved doses, three brand names, a significant cost difference, and a dose-response curve that flattens out way earlier than most people realize. Understanding the actual pharmacology saves you money and potentially side effects.

Two Doses, Two Brand Names, One Drug

Finasteride is the same molecule regardless of dose. But the FDA approved it at two different strengths for two different conditions:

1 mg/day (brand name: Propecia) — FDA-approved for male pattern hair loss (androgenetic alopecia). This is the standard hair loss dose.

5 mg/day (brand name: Proscar) — FDA-approved for benign prostatic hyperplasia (BPH), an enlarged prostate condition common in men over 50.

Same drug. Same manufacturer (Merck). Same mechanism. The only difference is the amount of active ingredient per tablet — and the price, which is where things get interesting.

The DHT Dose-Response Curve

Here's the data point that changes everything about how you think about finasteride dosing: the dose-response curve for DHT suppression is nearly flat above 1 mg.

Read that again. Going from 1 mg to 5 mg — a five-fold increase in drug exposure — only buys you about 5 percentage points of additional DHT reduction. The curve of diminishing returns is steep. The vast majority of finasteride's DHT-blocking effect is achieved at 1 mg or below.

This is why the FDA approved 1 mg for hair loss. You get the overwhelming majority of the benefit with a fraction of the drug. There's no clinical evidence that 5 mg produces meaningfully better hair outcomes than 1 mg.

Microdosing: Does 0.5mg or Every-Other-Day Work?

The microdosing trend has gained traction, particularly among men who want to minimize side effect risk while still getting meaningful DHT reduction. Here's what the data shows:

The rationale behind microdosing is sound: given the flat dose-response curve, even substantially lower doses achieve clinically relevant DHT suppression. And since the enzyme-inhibitor complex has a ~30 day half-life (meaning finasteride stays locked onto the enzyme for weeks), even intermittent dosing maintains meaningful inhibition.

The caveat: the formal clinical trial data that got finasteride approved was at 1 mg daily. Lower doses and alternate schedules are extrapolated from pharmacokinetic data and smaller studies. They're reasonable extrapolations, but they're not backed by large Phase III trials.

The practical takeaway: if you're experiencing side effects on 1 mg, dropping to 0.5 mg daily or 1 mg every other day is a legitimate option to discuss with your provider before abandoning the drug entirely.

The 5mg Pill-Splitting Cost Hack

Here's where the two-dose system actually works in your favor. Generic finasteride pricing has a quirk: the 5 mg tablet is often the same price or barely more expensive than the 1 mg tablet. Same drug, five times the content, nearly identical cost.

The cost hack: get a prescription for generic finasteride 5 mg (Proscar), buy a $5 pill splitter, and cut each tablet into quarters. Each quarter is approximately 1.25 mg — close enough to 1 mg that it's clinically equivalent given the flat dose-response curve.

The one downside: quartered tablets aren't perfectly uniform. You might get 1.4 mg one day and 0.9 mg the next. Given how flat the dose-response curve is between 0.5 mg and 5 mg, this variation is clinically meaningless. Your DHT suppression won't fluctuate in any meaningful way.

Topical Finasteride Dosing

Topical finasteride adds another layer to the dosing conversation. Available through compounding pharmacies and telehealth platforms like Happy Head, topical formulations typically range from 0.005% to 0.25% concentration.

The Phase III Piraccini trial used 0.25% topical finasteride and found it increased hair count by +20.2 compared to +6.7 for placebo, which was numerically similar to oral finasteride. But the systemic exposure was dramatically lower: plasma finasteride levels were over 100-fold lower with topical vs oral, and serum DHT reduction was only 34.5% (topical) vs 55.6% (oral).

The trade-off is real: potentially lower side effects, but less systemic DHT suppression and significantly higher cost ($40–$100+/month vs $3–$7/month for generic oral). Whether that trade-off is worth it depends on your individual risk tolerance and budget. (We cover this in depth in our topical vs oral finasteride comparison.)

The Bottom Line